Effect of Pin1 inhibitor juglone on proliferation, migration and angiogenic ability of breast cancer cell line MCF7Adr

Abstract

This study aimed to evaluate the effects of Pin1 inhibitor Juglone on proliferation, migration and the angiogenic ability of breast cancer cell line MCF7Adr. MCF7Adr cells were cultured and separately treated with Pin1 inhibitor Juglone (treatment group) and DMEM without drug (control group). The cell cycle was examined by flow cytometry. Cell migration was measured by wound-healing assay. Cyclin E protein content was detected by Western blotting. The angiogenesis factor vascular endothelial growth factor (VEGF) in cell media was determined by enzyme linked immunosorbent assay. The results showed that the percentage of cells in G₂/M phase in treatment group was significantly higher than that in control group (25.5% vs. 10.1%, P<0.05), and that in G₀/G₁ phase and S stage in treatment group was significantly lower than that in control group (40.5% vs. 48.2%, and 33.7% vs. 41.7%, P<0.05). Cyclin E protein content in treatment group was significantly lower than that in control group (39.2±7.4 vs. 100±23.1, P<0.05). (A₀–A₂₄)/A₀ value in treatment group was significantly lower than that in control group (23.9±3.8 vs. 100±14.4, P<0.05). VEGF-A, -B, and -C contents in cell media of treatment group were significantly lower than those in control group (P<0.05). It was suggested that Pin1 inhibitor Juglone can effectively inhibit the proliferation, migration and the angiogenic ability of MCF7Adr cells, and can be used as an alternative drug therapy for breast cancer.

Keywords

breast cancer / Pin1 inhibitor / cell cycle / angiogenesis

References

[1] Atrux-TallauN, CallejonS, MigdalC, et al. . Development and in vitro assay of oxidative stress modifying formulations for wound healing promotion. Eur J Dermatol, 2011, 21(2): 52-62 PMID: 21628131

[2] ChiWC, FuSF, HuangTL, et al. . Identification of transcriptome profiles and signaling pathways for the allelochemical juglone in rice roots. Plant Mol Biol, 2011, 77(6): 591-607 PMID: 22065257

[3] PiskorskiR, IneichenS, DornS. Ability of the oriental fruit Moth Grapholita molesta (Lepidoptera: Tortricidae) to detoxify Juglone, the main secondary metabolite of the non-host plant walnut. J Chem Ecol, 2011, 37(10): 1110-1116 PMID: 21901444

[4] ChobotV, HadacekF. Milieu-dependent pro- and antioxidant activity of juglone may explain linear and nonlinear effects on seedling development. J Chem Ecol, 2009, 35(3): 383-390 PMID: 19263168

[5] AithalKB, KumarS, RaoBN, et al. . Tumor growth inhibitory effect of juglone and its radiation sensitizing potential: in vivo and in vitro studies. Integr Cancer Ther, 2012, 11(1): 68-80 PMID: 21498474

[6] OhriN, DickerAP, LawrenceYR. Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data. Int J Radiat Oncol Biol Phys, 2012, 83(1): 385-393 PMID: 22265460

[7] von KiparskiGR, LeeLS, GillespieAR. Occurrence and fate of the phytotoxin juglone in alley soils under black walnut trees. J Environ Qual, 2007, 36(3): 709-717

[8] ChiassonVL, MunshiN, ChatterjeeP, et al. . Pin1 deficiency causes endothelial dysfunction and hypertension. Hypertension, 2011, 58(3): 431-438 PMCID: 4096767 PMID: 21810655

[9] Nicole-TsangYH, WuXW, LimJS, et al. . Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer. Oncogene, 2013, 32(12): 1488-1496 PMID: 22580604

[10] ZhangJ, HanXM, HuWH, et al. . Application of temperature sensitive yeast models with definite target in the screening of potential human Pin1 inhibitors. Yao Xue Xue Bao (Chinese), 2014, 49(6): 854-860